|
2026-04-15 16:20 |
2026-04-14 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
COO |
F - Tax |
$4.91 |
-1,069 |
629.6K |
-0.2% |
-$5,249 |
|
2026-03-23 |
2026-03-22 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
COO |
F - Tax |
$4.58 |
-2,055 |
630.7K |
-0.3% |
-$9,412 |
| M |
2026-03-16 |
2026-03-13+ |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
COO |
F - Tax |
$4.66 |
-29.3K |
652.9K |
-4% |
-$136.5K |
|
2026-03-16 |
2026-03-12 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
COO |
A - Grant |
$0.00 |
+247.4K |
662.1K |
+60% |
$0 |
|
2026-02-03 |
2026-02-02 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
COO |
A - Grant |
$0.00 |
+32.8K |
414.6K |
+9% |
$0 |
|
2025-09-22 |
2025-09-21 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
COO |
F - Tax |
$7.77 |
-1,085 |
381.8K |
-0.3% |
-$8,430 |
|
2025-04-15 |
2025-04-14 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$8.08 |
-1,085 |
382.9K |
-0.3% |
-$8,767 |
| M |
2025-03-25 |
2025-03-22+ |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$10.00 |
-7,690 |
390.3K |
-2% |
-$76.9K |
| M |
2025-03-17 |
2025-03-14+ |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$10.07 |
-9,576 |
391.7K |
-2% |
-$96.4K |
|
2025-03-17 |
2025-03-13 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
A - Grant |
$0.00 |
+99.2K |
401.3K |
+33% |
$0 |
|
2025-03-04 |
2025-02-07 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
A - Grant |
$0.00 |
+12.8K |
302.0K |
+4% |
$0 |
| M |
2024-10-10 |
2024-10-09 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$24.37 |
-8,363 |
294.3K |
-3% |
-$203.8K |
|
2024-09-23 |
2024-09-21 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$27.64 |
-1,075 |
297.6K |
-0.4% |
-$29.7K |
|
2024-04-15 |
2024-04-14 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$19.55 |
-1,076 |
298.7K |
-0.4% |
-$21.0K |
| M |
2024-03-25 |
2024-03-22+ |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$22.24 |
-4,893 |
303.0K |
-2% |
-$108.8K |
|
2024-03-18 |
2024-03-14 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
A - Grant |
$0.00 |
+58.6K |
308.4K |
+23% |
$0 |
|
2024-03-18 |
2024-03-15 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$21.16 |
-3,686 |
304.7K |
-1% |
-$78.0K |
| M |
2023-10-10 |
2023-10-09 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$15.01 |
-8,366 |
249.7K |
-3% |
-$125.6K |
|
2023-09-27 |
2023-09-26 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$15.99 |
-3,523 |
258.1K |
-1% |
-$56.3K |
|
2023-09-22 |
2023-09-21 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$16.77 |
-1,076 |
261.6K |
-0.4% |
-$18.0K |
|
2023-04-17 |
2023-04-14 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$22.27 |
-703 |
262.7K |
-0.3% |
-$15.7K |
| M |
2023-03-27 |
2023-03-24 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$23.72 |
-2,669 |
263.4K |
-1% |
-$63.3K |
|
2023-03-23 |
2023-03-22 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$22.91 |
-1,351 |
266.1K |
-0.5% |
-$31.0K |
|
2023-03-16 |
2023-03-15 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
A - Grant |
$0.00 |
+39.4K |
267.4K |
+17% |
$0 |
| M |
2022-10-11 |
2022-10-09 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$19.62 |
-8,366 |
233.0K |
-3% |
-$164.1K |
| M |
2022-09-27 |
2022-09-25+ |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$18.56 |
-5,086 |
236.4K |
-2% |
-$94.4K |
|
2022-09-22 |
2022-09-21 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$20.20 |
-702 |
241.5K |
-0.3% |
-$14.2K |
|
2022-08-26 |
2022-08-25 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
F - Tax |
$24.89 |
-1,031 |
242.2K |
-0.4% |
-$25.7K |
|
2022-04-14 |
2022-04-14 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Chief Commercial Off |
A - Grant |
$0.00 |
+10.0K |
243.2K |
+4% |
$0 |
| M |
2022-03-25 |
2022-03-24 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Pres, Mental Health |
F - Tax |
$25.32 |
-2,666 |
234.8K |
-1% |
-$67.5K |
|
2022-03-23 |
2022-03-22 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Pres, Mental Health |
A - Grant |
$0.00 |
+19.2K |
235.9K |
+9% |
$0 |
|
2022-02-18 |
2022-02-16 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Pres, Mental Health |
A - Grant |
$0.00 |
+22.6K |
216.6K |
+12% |
$0 |
| M |
2021-10-12 |
2021-10-09 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Pres, Myriad Neuroscience |
F - Tax |
$30.88 |
-8,340 |
194.0K |
-4% |
-$257.5K |
| M |
2021-09-27 |
2021-09-25+ |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Pres, Myriad Neuroscience |
F - Tax |
$33.31 |
-10.3K |
205.9K |
-5% |
-$341.8K |
| M |
2021-09-23 |
2021-09-21 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Pres, Myriad Neuroscience |
A - Grant |
$0.00 |
+56.6K |
212.6K |
+36% |
$0 |
|
2021-08-26 |
2021-08-25 |
MYGN |
MYRIAD GENETICS INC |
Verratti Mark |
Pres, Myriad Neuroscience |
F - Tax |
$34.81 |
-1,082 |
156.0K |
-0.7% |
-$37.7K |